Current:Home > MyAmy Schumer Says She Couldn't Play With Son Gene Amid Struggle With Ozempic Side Effects -AssetLink
Amy Schumer Says She Couldn't Play With Son Gene Amid Struggle With Ozempic Side Effects
View
Date:2025-04-14 00:36:10
Amy Schumer is getting candid about the side effects of Ozempic.
While the comedian "immediately invested" in the type 2 diabetes medication—which is now being popularly used as a weight-loss drugs in Hollywood—about a year ago, she said it left her unable to spend time with her and husband Chris Fischer's 4-year-old son, Gene.
"I was one of those people that felt so sick and couldn't play with my son," Amy explained on Watch What Happens Live with Andy Cohen on June 8, "I was so skinny, and he's throwing a ball at me and [I couldn't]."
Ultimately, the Trainwreck star decided using Ozempic was not "livable" for her. Nonetheless, she's still urging other celebrities to come clean about taking Ozempic.
"Everyone and their mom is gonna try it. Everyone has been lying saying, 'Oh, smaller portions,'" she continued. "Like, shut the f--k up. You are on Ozempic or one of those things, or you got work done. Just stop."
She added, "Be real with the people. When I got lipo, I said I got lipo."
The 42-year-old is not the only person to speak out about using Ozempic. Chelsea Handler and Tim McGraw's daughter Gracie have also shared their experiences, as well as Golnesa "GG" Gharachedaghi.
Gracie said on Instagram she used Ozempic to assist with her polycystic ovary syndrome diagnosis, while Chelsea revealed in January that she was prescribed the medication.
"My anti-aging doctor just hands it out to anybody," the 47-year-old said on Call Her Daddy. "I didn't even know I was on it. She said, 'If you ever want to drop five pounds, this is good.'"
As for Golnesa, she was open about using injection shots of Semaglutide—the generic version of Ozempic—for weight loss.
"I don't see a reason to hide being on a weight loss [medication] or a cosmetic procedure," the Shahs of Sunset star told Entertainment Tonight last month, "just talk about it because there's so many people out there who want to do the same thing or they want to learn about what you did."
A rep for the pharmaceutical company Novo Nordisk, which makes Ozempic, previously told E! News in a statement that Ozempic is "not approved for chronic weight management." The organization said that Ozempic is intended to treat type 2 diabetes, improve blood sugar and minimize risks of major cardiovascular events for adults with the condition.
For the latest breaking news updates, click here to download the E! News AppveryGood! (3)
Related
- Federal appeals court upholds $14.25 million fine against Exxon for pollution in Texas
- Narcissists are terrible parents. Experts say raising kids with one can feel impossible.
- Highland Park suspected shooter's father pleads guilty to reckless conduct
- Chicago Cubs hire manager Craig Counsell away from Milwaukee in surprising move
- US wholesale inflation accelerated in November in sign that some price pressures remain elevated
- As coal miners suffer and die from severe black lung, a proposed fix may fall short
- The Air Force asks Congress to protect its nuclear launch sites from encroaching wind turbines
- Man, 23, arrested in slaying of grandmother found decapitated in California home
- Questlove charts 50 years of SNL musical hits (and misses)
- Below Deck Med's Captain Sandy Yawn Suffers Scary Injury Leaving Her Season 8 Future in Jeopardy
Ranking
- Senate begins final push to expand Social Security benefits for millions of people
- New Mexico revisits tax credits for electric vehicles after governor’s veto
- Israel-Hamas war crowds crisis-heavy global agenda as Blinken, G7 foreign ministers meet in Japan
- 'Rap Sh!t' is still musing on music and art of making it
- Dick Vitale announces he is cancer free: 'Santa Claus came early'
- Below Deck Med's Captain Sandy Yawn Suffers Scary Injury Leaving Her Season 8 Future in Jeopardy
- What to know about Issue 1 in Ohio, the abortion access ballot measure, ahead of Election Day 2023
- Who was Muhlaysia Booker? Here’s what to know after the man accused of killing her pleaded guilty
Recommendation
Toyota to invest $922 million to build a new paint facility at its Kentucky complex
Civilians fleeing northern Gaza’s combat zone report a terrifying journey on foot past Israeli tanks
Protesters calling for Gaza cease-fire block road at Tacoma port while military cargo ship docks
Depression affects 1 in 5 people. Here's what it feels like.
EU countries double down on a halt to Syrian asylum claims but will not yet send people back
Tennessean and USA TODAY Network appoint inaugural Taylor Swift reporter
After 20 years, Boy George is returning to Broadway in 'Moulin Rouge! The Musical'
Powerball lottery jackpot climbs to $179 million: Here's what to know before next drawing